30 B&W Landscape Logo.jpg
30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
April 19, 2023 02:06 ET | 30 Technology
PRESS RELEASE 30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications Transaction total value up to £176 million Strategic...
logo.png
Ashvattha Therapeutics Presented Promising Preclinical Data on Novel Macrophage Switching Nanomedicine D-4559 at AACR Annual Meeting
April 18, 2023 09:00 ET | Ashvattha Therapeutics
Data demonstrated D-4559 switches tumor associated macrophages from an M2 to M1 pro-inflammatory phenotype leading to reduction in tumor growth in a mouse model of hepatocellular carcinomaThe data...
FINAL lOGO.png
Anti-VEGF Market to Cross US$ 34.9 billion Revenues between 2023 and 2033 - Persistence Market Research
April 18, 2023 08:42 ET | Persistence Market Research
New York, April 18, 2023 (GLOBE NEWSWIRE) -- Backed by the rising need for VEGF inhibitors in cancer therapy, the global Anti-VEGF Market was valued at US$ 22.7 billion in 2022 and is predicted to...
LUMIBIRD RECEIVES MA
LUMIBIRD RECEIVES MARKETING APPROVAL IN CHINA FOR ITS VITRA 2 PHOTOCOAGULATOR
April 17, 2023 11:45 ET | Lumibird SA
Lannion, 17 April 2023– 17h45 LUMIBIRD RECEIVES MARKETING APPROVAL IN CHINA FOR ITS VITRA 2 PHOTOCOAGULATOR The LUMIBIRD Group (FR0000038242 - LBIRD), the European leader for laser technologies,...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Optical Coherence Tomography Market Size to Cross US$ 10.5 Billion in 2032 | 13.7% CAGR
April 17, 2023 05:23 ET | Market.Us
New York, April 17, 2023 (GLOBE NEWSWIRE) -- According to Market.us, The global optical coherence tomography market is estimated to be valued at USD 10.5 billion by 2032 from USD 3 billion in 2022...
Ocular Logo.png
Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 14, 2023 16:01 ET | Ocular Therapeutix, Inc.
BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Adaptive Optics Market Predicted to Garner USD 4,296 Mn By 2032, At CAGR 25.1% | Market.us
April 14, 2023 09:33 ET | Market.Us
New York, April 14, 2023 (GLOBE NEWSWIRE) -- The global Adaptive Optics market is estimated to be valued at USD 4296 million by 2032 from USD 484 million in 2022 and is expected to exhibit a CAGR of...
Arjun (Left) and Martin (Right) - Lab - 1 (Press)
Researchers Discover a New Embryonic Brain Circuit   EMBARGOED UNTIL 17-APR-2023 11:00 ET   The findings may provide new insights into circuit abnormalities in autism. ...
KRYS logo no_background.png
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
April 13, 2023 07:00 ET | Krystal Biotech, Inc.
Clinical data on the compassionate use of B-VEC to treat a RDEB patient, with recurrent cicatrizing conjunctivitis that leads to conjunctival scarring, at the Bascom Palmer Eye Institute PITTSBURGH,...
roche-logo-blue.png
Roche data highlights strength of ophthalmology portfolio and commitment to advancing eye care at ARVO 2023
April 13, 2023 01:00 ET | F. Hoffmann-La Roche Ltd
Vabysmo data suggest rapid and robust drying of retinal fluid in patients with neovascular or ‘wet’ age-related macular degeneration and diabetic macular edema Real-world studies of Vabysmo...